Kathleen W Scotto

Title: Innovations by Kathleen W. Scotto

Introduction

Kathleen W. Scotto is an accomplished inventor based in Washington Crossing, PA (US). She has made significant contributions to the field of cancer research, particularly in the area of hormone-refractory prostate cancer. With a total of 2 patents, her work has the potential to impact treatment options for patients suffering from this challenging condition.

Latest Patents

Kathleen's latest patents focus on E2F as a target for hormone-refractory prostate cancer. The inventions provide amino acid sequences that compete with E2F for DNA binding. Additionally, methods for using these amino acid sequences for the treatment of hormone-refractory prostate cancer are also included in her patents. This innovative approach could lead to new therapeutic strategies in oncology.

Career Highlights

Kathleen W. Scotto is affiliated with Rutgers, the State University of New Jersey, where she continues her research and development efforts. Her work is characterized by a commitment to advancing scientific knowledge and improving patient outcomes through innovative solutions.

Collaborations

Some of her notable coworkers include Xiaoqi Xie and John E. Kerrigan. Their collaborative efforts contribute to the ongoing research and development in the field of cancer treatment.

Conclusion

Kathleen W. Scotto's contributions to cancer research through her patents and collaborations highlight her dedication to innovation in medicine. Her work has the potential to change the landscape of treatment for hormone-refractory prostate cancer.